Filing Details

Accession Number:
0001144204-13-040770
Form Type:
4
Zero Holdings:
No
Publication Time:
2013-07-23 20:48:17
Reporting Period:
2012-12-10
Filing Date:
2013-07-23
Accepted Time:
2013-07-23 19:48:17
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1420030 Targeted Medical Pharma Inc. NONE Pharmaceutical Preparations (2834) 205863618
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1509917 William Shell C/O Targeted Medical Pharma, Inc.
2980 Beverly Glen Circle, Suite 301
Los Angeles CA 90077
Ceo & Chief Scientific Officer Yes Yes Yes No
1511770 Trust Family Shell William & Charuvastra Elizabeth 3048 Nicada Drive
Los Angeles CA 90077
No No Yes No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock, $.001 Par Value Per Share Acquisiton 2013-01-10 1,000 $2.30 29,400 No 4 P Indirect By trust
Common Stock, $.001 Par Value Per Share Acquisiton 2013-01-09 500 $2.30 28,400 No 4 P Indirect By trust
Common Stock, $.001 Par Value Per Share Acquisiton 2013-01-07 200 $2.45 27,900 No 4 P Indirect By trust
Common Stock, $.001 Par Value Per Share Acquisiton 2013-01-03 2,000 $2.16 3,000 No 4 P Indirect By trust
Common Stock, $.001 Par Value Per Share Acquisiton 2013-01-03 1,500 $2.47 27,700 No 4 P Indirect By trust
Common Stock, $.001 Par Value Per Share Acquisiton 2012-12-28 500 $2.70 26,200 No 4 P Indirect By trust
Common Stock, $.001 Par Value Per Share Acquisiton 2012-12-24 2,500 $2.61 25,700 No 4 P Indirect By trust
Common Stock, $.001 Par Value Per Share Acquisiton 2012-12-14 2,700 $4.59 23,200 No 4 P Indirect By trust
Common Stock, $.001 Par Value Per Share Acquisiton 2012-12-14 700 $5.54 20,500 No 4 P Indirect By trust
Common Stock, $.001 Par Value Per Share Acquisiton 2012-12-13 4,000 $4.88 19,800 No 4 P Indirect By trust
Common Stock, $.001 Par Value Per Share Acquisiton 2012-12-12 1,100 $3.50 15,800 No 4 P Indirect By trust
Common Stock, $.001 Par Value Per Share Acquisiton 2012-12-12 700 $4.71 14,700 No 4 P Indirect By trust
Common Stock, $.001 Par Value Per Share Acquisiton 2012-12-11 5,000 $4.21 14,000 No 4 P Indirect By trust
Common Stock, $.001 Par Value Per Share Acquisiton 2012-12-10 1,000 $3.35 1,000 No 4 P Indirect By trust
Common Stock, $.001 Par Value Per Share Acquisiton 2012-12-10 4,000 $3.31 9,000 No 4 P Indirect By trust
Common Stock, $.001 Par Value Per Share Acquisiton 2012-12-07 5,000 $3.50 5,000 No 4 P Indirect By trust
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 P Indirect By trust
No 4 P Indirect By trust
No 4 P Indirect By trust
No 4 P Indirect By trust
No 4 P Indirect By trust
No 4 P Indirect By trust
No 4 P Indirect By trust
No 4 P Indirect By trust
No 4 P Indirect By trust
No 4 P Indirect By trust
No 4 P Indirect By trust
No 4 P Indirect By trust
No 4 P Indirect By trust
No 4 P Indirect By trust
No 4 P Indirect By trust
No 4 P Indirect By trust
Footnotes
  1. Common stock and warrants are held by Willliam Shell Survivor's Trust.
  2. Common stock is held by Elizabeth Charuvastra Exemption Trust. William E. Shell is voluntarily filing on behalf of the Elizabeth Charuvastra Exemption Trust and disclaims any and all pecuniary interest in the Elizabeth Charuvastra Exemption Trust.
  3. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $2.35 to $2.40 per share.
  4. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $2.55 to $2.65 per share.
  5. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $4.00 to $4.75 per share.
  6. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $5.00 to $5.75 per share.
  7. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $4.75 to $5.00 per share.
  8. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $4.50 to $4.75 per share.
  9. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $3.75 to $4.50 per share.
  10. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $3.20 to $3.35 per share.
  11. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $1.64 to $1.75 per share.